newsfilter
← Latest News
Business Wire·

Ambrx Raises $78 Million and Completes its ATM Program

Ambrx Biopharma Inc., or Ambrx (NYSE:AMAM), today announced that it has completed net sales of approximately $78 million of American Depositary Shares ("ADSs") pursuant to the Company's at-the-market ("ATM") program